X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (712) 712
microscopic polyangiitis (650) 650
index medicus (447) 447
female (421) 421
vasculitis (393) 393
male (392) 392
middle aged (328) 328
wegeners-granulomatosis (318) 318
aged (310) 310
rheumatology (276) 276
adult (252) 252
antibodies, antineutrophil cytoplasmic - immunology (208) 208
systemic vasculitis (207) 207
antibodies, antineutrophil cytoplasmic - blood (172) 172
anca (170) 170
anca-associated vasculitis (170) 170
vasculitis - immunology (166) 166
antineutrophil cytoplasmic antibodies (165) 165
peroxidase - immunology (159) 159
immunosuppressive agents - therapeutic use (158) 158
urology & nephrology (152) 152
churg-strauss-syndrome (149) 149
autoantibodies (138) 138
immunology (138) 138
granulomatosis with polyangiitis - immunology (137) 137
treatment outcome (134) 134
wegener's granulomatosis (133) 133
glomerulonephritis (126) 126
microscopic polyangiitis - immunology (113) 113
disease (110) 110
retrospective studies (110) 110
polyarteritis-nodosa (109) 109
anti-neutrophil cytoplasmic antibody-associated vasculitis - immunology (108) 108
granulomatosis with polyangiitis (104) 104
antibody-associated vasculitis (95) 95
aged, 80 and over (94) 94
cyclophosphamide (94) 94
medicine & public health (93) 93
cyclophosphamide - therapeutic use (92) 92
prognosis (92) 92
adolescent (86) 86
antibodies (86) 86
randomized-trial (84) 84
classification (83) 83
recurrence (83) 83
myeloperoxidase (82) 82
medicine, general & internal (77) 77
rituximab (77) 77
small-vessel vasculitis (77) 77
granulomatosis (76) 76
granulomatosis with polyangiitis - diagnosis (71) 71
biopsy (70) 70
microscopic polyangiitis - diagnosis (70) 70
therapy (68) 68
antibodies, antineutrophil cytoplasmic - analysis (67) 67
diagnosis (67) 67
vasculitis - diagnosis (67) 67
remission induction (66) 66
churg-strauss syndrome (65) 65
myeloblastin - immunology (65) 65
microscopic polyangiitis - complications (64) 64
crescentic glomerulonephritis (63) 63
autoimmunity (62) 62
risk factors (62) 62
microscopic polyangiitis - drug therapy (61) 61
abridged index medicus (60) 60
antineutrophil cytoplasmic autoantibodies (60) 60
glomerulonephritis - immunology (59) 59
term-follow-up (59) 59
anti-neutrophil cytoplasmic antibody-associated vasculitis - drug therapy (57) 57
churg-strauss syndrome - immunology (57) 57
diagnosis, differential (57) 57
granulomatosis with polyangiitis - drug therapy (56) 56
biomarkers - blood (55) 55
young adult (55) 55
vasculitis - complications (54) 54
anti-neutrophil cytoplasmic antibody-associated vasculitis - diagnosis (53) 53
severity of illness index (52) 52
vasculitis - drug therapy (51) 51
analysis (49) 49
antineutrophil cytoplasmic antibody (49) 49
neutrophils (49) 49
systemic-lupus-erythematosus (49) 49
nephrology (48) 48
neutrophils - immunology (48) 48
remission (48) 48
animals (47) 47
care and treatment (47) 47
child (47) 47
drug therapy, combination (47) 47
glucocorticoids - therapeutic use (47) 47
epidemiology (46) 46
rheumatoid-arthritis (45) 45
vasculitis - pathology (45) 45
case-control studies (44) 44
churg-strauss syndrome - diagnosis (44) 44
eosinophilic granulomatosis with polyangiitis (44) 44
pathogenesis (44) 44
vasculitis - therapy (44) 44
viral antibodies (44) 44
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (782) 782
Japanese (12) 12
German (10) 10
French (8) 8
Spanish (7) 7
Russian (3) 3
Chinese (1) 1
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Arthritis & Rheumatology, ISSN 2326-5191, 12/2016, Volume 68, Issue 12, pp. 2945 - 2952
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 12/2016, Volume 68, Issue 12, pp. 2953 - 2963
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2015, Volume 74, Issue 6, pp. 1178 - 1182
Objectives The RITUXVAS trial reported similar remission induction rates and safety between rituximab and cyclophosphamide based regimens for antineutrophil... 
MAINTENANCE | Cyclophosphamide | Treatment | ANTIBODY-ASSOCIATED VASCULITIS | THERAPY | Granulomatosis with polyangiitis | ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES | B cells | RHEUMATOLOGY | Systemic vasculitis | Azathioprine - therapeutic use | Glucocorticoids - therapeutic use | Renal Insufficiency, Chronic - etiology | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Microscopic Polyangiitis - complications | Cyclophosphamide - therapeutic use | Renal Insufficiency, Chronic - drug therapy | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - complications | Granulomatosis with Polyangiitis - immunology | Female | Microscopic Polyangiitis - immunology | Drug Therapy, Combination | B-Lymphocytes - cytology | Renal Insufficiency, Chronic - immunology | Rituximab | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy | Disease Progression | Disease-Free Survival | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - immunology | Lymphocyte Count | Microscopic Polyangiitis - drug therapy | Granulomatosis with Polyangiitis - drug therapy | Aged | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Granulomatosis with Polyangiitis - complications | Kidney Failure, Chronic - etiology | Usage | Care and treatment | Vasculitis | Patient outcomes | Clinical trials | Dosage and administration | Comparative analysis | Risk factors | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | B cells; Cyclophosphamide; Granulomatosis with polyangiitis; Systemic vasculitis; Treatment | Medicin och hälsovetenskap
Journal Article
Clinical and Experimental Immunology, ISSN 0009-9104, 04/2017, Volume 188, Issue 1, pp. 174 - 181
Journal Article
Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 10/2017, Volume 12, Issue 10, pp. 1680 - 1691
ANCA vasculitis has an associated autoimmune response that produces ANCAs that induce distinct pathologic lesions. Pauci-immune necrotizing and crescentic GN... 
Autoimmunity | Glomerulonephritis | Antineutrophil cytoplasmic | Recurrence | Autoantibodies | Prevalence | Neutrophils | Serogroup | Antibodies | Microscopic polyangiitis | Neutrophil activation | Vasculitis | ANCA | Churg-strauss syndrome | Animal | Granulomatosis with polyangiitis | Models | Peroxidase | Myeloblastin | ANTIBODY-ASSOCIATED VASCULITIS | DAILY ORAL CYCLOPHOSPHAMIDE | RENAL VASCULITIS | ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES | UROLOGY & NEPHROLOGY | TERM-FOLLOW-UP | RANDOMIZED-TRIAL | CLINICAL-FEATURES | AFRICAN-AMERICANS | SMALL-VESSEL VASCULITIS | MAINTENANCE THERAPY | Granulomatosis with Polyangiitis - diagnosis | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Glomerulonephritis - diagnosis | Male | Microscopic Polyangiitis - epidemiology | Churg-Strauss Syndrome - epidemiology | Churg-Strauss Syndrome - drug therapy | Granulomatosis with Polyangiitis - immunology | Female | Microscopic Polyangiitis - immunology | Glomerulonephritis - epidemiology | Peroxidase - immunology | Myeloblastin - immunology | Risk Factors | Granulomatosis with Polyangiitis - epidemiology | Glomerulonephritis - immunology | Treatment Outcome | Microscopic Polyangiitis - diagnosis | Remission Induction | Glomerulonephritis - drug therapy | Animals | Churg-Strauss Syndrome - diagnosis | Microscopic Polyangiitis - drug therapy | Granulomatosis with Polyangiitis - drug therapy | Churg-Strauss Syndrome - immunology | Antibodies, Antineutrophil Cytoplasmic - blood | Index Medicus | Neutrophil Activation | Glomerular Diseases | vasculitis | Update for the Clinician | Granulomatosis with Polyangiitis | Churg-Strauss Syndrome | Antineutrophil Cytoplasmic | glomerulonephritis | Microscopic Polyangiitis
Journal Article
Rheumatology, ISSN 1462-0324, 10/2011, Volume 50, Issue 10, pp. 1916 - 1920
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2016, Volume 75, Issue 6, pp. 1166 - 1169
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2013, Volume 72, Issue 6, pp. 1003 - 1010
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2017, Volume 12, Issue 10, pp. e0185880 - e0185880
Objectives The treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is based on remission-induction and remission-maintenance.... 
WEGENERS-GRANULOMATOSIS | CHURG-STRAUSS-SYNDROME | ANTIBODY-ASSOCIATED VASCULITIS | EOSINOPHILIC GRANULOMATOSIS | RENAL VASCULITIS | RITUXIMAB | MULTIDISCIPLINARY SCIENCES | AZATHIOPRINE | CLASSIFICATION | POOR-PROGNOSIS FACTORS | RHEUMATOLOGY 1990 CRITERIA | Recurrence | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Methotrexate - therapeutic use | Microscopic Polyangiitis - complications | Cyclophosphamide - therapeutic use | Microscopic Polyangiitis - mortality | Patient Selection | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - mortality | Churg-Strauss Syndrome - drug therapy | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - complications | Granulomatosis with Polyangiitis - immunology | Patient Safety | Adult | Female | Microscopic Polyangiitis - immunology | Peripheral Nervous System Diseases - complications | Peripheral Nervous System Diseases - immunology | Proteinuria - mortality | Peripheral Nervous System Diseases - mortality | Granulomatosis with Polyangiitis - mortality | Proteinuria - immunology | Treatment Outcome | Random Allocation | Remission Induction | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy | Churg-Strauss Syndrome - complications | Proteinuria - drug therapy | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - immunology | Churg-Strauss Syndrome - mortality | Adolescent | Survival Analysis | Microscopic Polyangiitis - drug therapy | Granulomatosis with Polyangiitis - drug therapy | Aged | Churg-Strauss Syndrome - immunology | Proteinuria - complications | Peripheral Nervous System Diseases - drug therapy | Antibodies, Antineutrophil Cytoplasmic - blood | Granulomatosis with Polyangiitis - complications | Complications and side effects | Cyclophosphamide | Vasculitis | Dosage and administration | Genetic aspects | Research | Methotrexate | Drug therapy | Nephrology | Transplants & implants | Hemodialysis | Toxicity | Granulomatosis | Arthritis | Peripheral neuropathy | Randomization | Antineutrophil cytoplasmic antibodies | Remission | Drug dosages | Kidneys | Internal medicine | Epidermal growth factor receptors | Leukocytes (eosinophilic) | Rheumatology | Maintenance | Patients | Medicine | Hospitals | Medical prognosis | Proteinuria | Kidney transplantation | Index Medicus
Journal Article
Pediatric Nephrology, ISSN 0931-041X, 10/2012, Volume 27, Issue 10, pp. 1911 - 1920
Antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis and systemic vasculitis (AAGNV) is uncommon in childhood.This is a retrospective study... 
Pediatrics | Microscopic polyangiitis | Medicine & Public Health | Necrotizing glomerulonephritis | Childhood | Wegener granulomatosis | ANCA-associated vasculitis | AUTOANTIBODIES | POLYANGIITIS | CLASSIFICATION | CHILDREN | ANTINEUTROPHIL CYTOPLASMIC ANTIBODY | INTERNATIONAL CONSENSUS STATEMENT | RECOMMENDATIONS | PEDIATRIC-PATIENTS | POLYARTERITIS | UROLOGY & NEPHROLOGY | PEDIATRICS | Cyclophosphamide - administration & dosage | Glomerulonephritis - therapy | Glucocorticoids - administration & dosage | Age Factors | Kidney - pathology | Granulomatosis with Polyangiitis - therapy | Humans | Kidney - immunology | England | Male | Microscopic Polyangiitis - complications | Plasma Exchange | Granulomatosis with Polyangiitis - immunology | Female | Granulomatosis with Polyangiitis - physiopathology | Microscopic Polyangiitis - immunology | Retrospective Studies | Acute Kidney Injury - immunology | Drug Therapy, Combination | Glomerulonephritis - physiopathology | Child | Granulomatosis with Polyangiitis - pathology | Immunosuppressive Agents - administration & dosage | Kidney - physiopathology | Microscopic Polyangiitis - physiopathology | Kidney Failure, Chronic - immunology | Glomerular Filtration Rate | Kidney - drug effects | Renal Insufficiency, Chronic - immunology | Proteinuria - immunology | Risk Assessment | Risk Factors | Glomerulonephritis - immunology | Treatment Outcome | Pulse Therapy, Drug | Disease Progression | Microscopic Polyangiitis - therapy | Glomerulonephritis - pathology | Adolescent | Microscopic Polyangiitis - pathology | Antibodies, Antineutrophil Cytoplasmic - blood | Granulomatosis with Polyangiitis - complications | Methylprednisolone - administration & dosage
Journal Article
Journal of Rheumatology, ISSN 0315-162X, 09/2012, Volume 39, Issue 9, pp. 1840 - 1843
Journal Article